Search Results
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK
Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Search for other papers by Estelle Healy in
Google Scholar
PubMed
Search for other papers by Philip Weir in
Google Scholar
PubMed
Search for other papers by Madhu Basetti in
Google Scholar
PubMed
Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Search for other papers by Steven J Hunter in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
coincidental. Succinate dehydrogenase (SDH) gene variants (collectively known as SDHx ) can associate with PPGL ( Baysal et al. 2000 ). The association of PitNET and PPGL in the setting of SDHx variant was established at the molecular level in 2012
Search for other papers by Susan Richter in
Google Scholar
PubMed
Search for other papers by Timothy J Garrett in
Google Scholar
PubMed
Search for other papers by Nicole Bechmann in
Google Scholar
PubMed
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Search for other papers by Hans K Ghayee in
Google Scholar
PubMed
identify the underlying cause, and patients who have a confirmed mutation in an SDHx gene but no PPGL yet should undergo regular follow-up ( Lenders et al. 2014 , Amar et al. 2021 ). Besides PPGL, SDHx PVs predispose to renal cell carcinomas
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed
( Lenders et al. 2020 ); (c) 2021 International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers outlining the most important considerations and diagnostic steps in the assessment of SDHx carriers ( Amar et al. 2021
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
( Buffet et al. 2019 ). The study compared the management and outcome of 221 patients diagnosed with PGL carrying mutations in SDHx or VHL who were informed of their positive genetic status either within the first year or more than 7 years after the
Search for other papers by David Taïeb in
Google Scholar
PubMed
Search for other papers by Christelle Fargette in
Google Scholar
PubMed
Search for other papers by Abhishek Jha in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
. 2008 , Taieb et al. 2009 ). SDHx -related metastatic PPGL typically exhibit a strong positivity in 18 F-FDG and SSTR PET, and a very limited uptake with specific tracers such as 18 F-FDOPA and 123 I-MIBG. This illustrates that the choice of
Search for other papers by Arthur S Tischler in
Google Scholar
PubMed
Search for other papers by Judith Favier in
Google Scholar
PubMed
SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas . Cell Reports 38 110453. ( https://doi.org/10.1016/j.celrep.2022.110453 ) Barthez PY Marks SL Woo J Feldman EC
Search for other papers by Jared S Rosenblum in
Google Scholar
PubMed
Search for other papers by Herui Wang in
Google Scholar
PubMed
Search for other papers by Matthew A Nazari in
Google Scholar
PubMed
Search for other papers by Zhengping Zhuang in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
the time, defects in genes putatively related to hypoxia signaling pathways such as VHL (von Hippel–Lindau), EGLN1 , and SDHx (succinate dehydrogenase complex genes) had been associated with neural crest tumors prior to our discovery ( Neumann